Related Guidance, Tools & Templates
- FDA Guidance for Clinical Trial Sponsors
- NIH Policy for Data and Safety Monitoring
- Further Guidance on a Data and Safety Monitoring for Phase I and Phase II Trials
- FDA Guidance: Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring
- FDA Webinar: Risk-based Approach to Monitoring Clinical Investigations
UCLA Presentations: